1. Home
  2. GMED vs MDGL Comparison

GMED vs MDGL Comparison

Compare GMED & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globus Medical Inc.

GMED

Globus Medical Inc.

HOLD

Current Price

$87.68

Market Cap

11.7B

Sector

Health Care

ML Signal

HOLD

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$582.45

Market Cap

12.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GMED
MDGL
Founded
2003
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.7B
12.5B
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
GMED
MDGL
Price
$87.68
$582.45
Analyst Decision
Buy
Strong Buy
Analyst Count
15
14
Target Price
$92.42
$580.77
AVG Volume (30 Days)
1.3M
268.0K
Earning Date
02-19-2026
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
358.86
N/A
EPS
3.08
N/A
Revenue
$2,769,804,000.00
$740,640,000.00
Revenue This Year
$16.86
$435.63
Revenue Next Year
$8.05
$52.56
P/E Ratio
$28.35
N/A
Revenue Growth
11.75
864.21
52 Week Low
$51.79
$265.00
52 Week High
$94.93
$615.00

Technical Indicators

Market Signals
Indicator
GMED
MDGL
Relative Strength Index (RSI) 55.75 57.70
Support Level $87.61 $578.00
Resistance Level $89.12 $615.00
Average True Range (ATR) 1.65 19.08
MACD -0.63 -1.59
Stochastic Oscillator 54.00 63.20

Price Performance

Historical Comparison
GMED
MDGL

About GMED Globus Medical Inc.

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

Share on Social Networks: